Michael  Rice net worth and biography

Michael Rice Biography and Net Worth

Michael Rice is the CEO of BioLife Solutions, a leading supplier of class-defining cell and gene therapy bioproduction tools and services. 

Rice joined the company in 2006 as president, CEO and director, and he served as chairman of the board from 2007 to 2013. In his last five years with the company, Rice has driven annual revenue growth to greater than 30 percent. During his tenure, BioLife has twice been named one of Seattle Business Magazine’s 100 Best Companies to Work For.

Prior to BioLife, Rice spent two years as the senior business development manager of medical and wireless products for AMI Semiconductor Inc. His career includes 30 years of experience in leadership and entrepreneurial roles in the medical and high-tech industries, including a four-year stint at Cardiac Science where he worked as the director of business development and marketing. From 1998 to 2000, Rice served as VP of sales and marketing for TEGRIS Corporation, a privately-held network services provider.

Early in his career, Rice held a series of marketing and sales management roles at Physio Control Corporation before it was acquired by Medtronic. He currently serves on the board of Sexton Biotechnologies, and he was formerly a board member for Savsu Technologies from 2014 to 2019. 

Rice earned his B.S. in business administration from City University of Seattle.  

What is Michael Rice's net worth?

The estimated net worth of Michael Rice is at least $4.57 million as of October 30th, 2023. Mr. Rice owns 347,085 shares of BioLife Solutions stock worth more than $4,567,639 as of December 6th. This net worth estimate does not reflect any other investments that Mr. Rice may own. Additionally, Mr. Rice receives a salary of $1,030,000.00 as CEO at BioLife Solutions. Learn More about Michael Rice's net worth.

How old is Michael Rice?

Mr. Rice is currently 60 years old. There are 6 older executives and no younger executives at BioLife Solutions. Learn More on Michael Rice's age.

What is Michael Rice's salary?

As the CEO of BioLife Solutions, Inc., Mr. Rice earns $1,030,000.00 per year. Learn More on Michael Rice's salary.

How do I contact Michael Rice?

The corporate mailing address for Mr. Rice and other BioLife Solutions executives is 3303 MONTE VILLA PARKWAY SUITE 310, BOTHELL WA, 98021. BioLife Solutions can also be reached via phone at (425) 402-1400 and via email at [email protected]. Learn More on Michael Rice's contact information.

Has Michael Rice been buying or selling shares of BioLife Solutions?

During the past quarter, Michael Rice has sold $662,865.39 of BioLife Solutions stock. Most recently, Michael Rice sold 72,603 shares of the business's stock in a transaction on Monday, October 30th. The shares were sold at an average price of $9.13, for a transaction totalling $662,865.39. Following the completion of the sale, the chief executive officer now directly owns 347,085 shares of the company's stock, valued at $3,168,886.05. Learn More on Michael Rice's trading history.

Who are BioLife Solutions' active insiders?

BioLife Solutions' insider roster includes Sarah Aebersold (VP), Todd Berard (CMO), Roderick de Greef (CFO), Karen Foster (Insider), Andrew Hinson (Director), Aby Mathew (VP), Michael Rice (CEO), Joseph Schick (Director), Marcus Schulz (CRO), and Troy Wichterman (CFO). Learn More on BioLife Solutions' active insiders.

Are insiders buying or selling shares of BioLife Solutions?

In the last twelve months, BioLife Solutions insiders bought shares 5 times. They purchased a total of 1,055,603 shares worth more than $12,648,274.13. In the last twelve months, insiders at the medical equipment provider sold shares 101 times. They sold a total of 258,921 shares worth more than $4,605,902.76. The most recent insider tranaction occured on December, 1st when insider Karen A Foster sold 466 shares worth more than $5,764.42. Insiders at BioLife Solutions own 2.7% of the company. Learn More about insider trades at BioLife Solutions.

Information on this page was last updated on 12/1/2023.

Michael Rice Insider Trading History at BioLife Solutions

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/30/2023Sell72,603$9.13$662,865.39347,085View SEC Filing Icon  
9/28/2023Sell831$14.16$11,766.96418,635View SEC Filing Icon  
8/25/2023Sell1,729$10.99$19,001.71416,906View SEC Filing Icon  
8/14/2023Sell277$12.38$3,429.26418,635View SEC Filing Icon  
6/27/2023Sell877$22.91$20,092.07418,912View SEC Filing Icon  
5/31/2023Sell1,679$23.21$38,969.59419,789View SEC Filing Icon  
5/17/2023Sell33,333$21.04$701,326.32421,468View SEC Filing Icon  
5/15/2023Sell190$18.71$3,554.90454,801View SEC Filing Icon  
4/6/2023Sell3,214$20.03$64,376.42447,480View SEC Filing Icon  
3/29/2023Sell936$20.62$19,300.32450,694View SEC Filing Icon  
3/7/2023Sell549$22.95$12,599.55451,630View SEC Filing Icon  
3/1/2023Sell4,290$22.75$97,597.50452,179View SEC Filing Icon  
2/9/2023Sell144$24.60$3,542.40456,469View SEC Filing Icon  
12/28/2022Sell898$16.90$15,176.20357,575View SEC Filing Icon  
11/29/2022Sell931$19.93$18,554.83358,473View SEC Filing Icon  
11/10/2022Sell164$23.16$3,798.24362,154View SEC Filing Icon  
9/29/2022Sell830$23.02$19,106.60362,318View SEC Filing Icon  
8/10/2022Sell171$23.17$3,962.07363,550View SEC Filing Icon  
6/28/2022Sell889$14.86$13,210.54361,452View SEC Filing Icon  
5/27/2022Sell749$14.53$10,882.97360,541View SEC Filing Icon  
5/13/2022Sell165$12.32$2,032.80360,326View SEC Filing Icon  
4/18/2022Sell24,400$17.59$429,196.00360,491View SEC Filing Icon  
4/13/2022Sell10,000$19.06$190,600.00384,891View SEC Filing Icon  
4/11/2022Sell10,000$19.55$195,500.00327,155View SEC Filing Icon  
3/29/2022Sell830$22.24$18,459.20View SEC Filing Icon  
3/9/2022Sell10,000$23.81$238,100.00View SEC Filing Icon  
3/7/2022Sell10,000$23.80$238,000.00View SEC Filing Icon  
3/1/2022Sell874$23.78$20,783.72View SEC Filing Icon  
2/10/2022Sell690$29.38$20,272.20View SEC Filing Icon  
2/3/2022Sell16,670$27.84$464,092.80View SEC Filing Icon  
2/1/2022Sell16,666$29.90$498,313.40View SEC Filing Icon  
1/12/2022Sell16,666$31.72$528,645.52View SEC Filing Icon  
1/10/2022Sell16,666$30.83$513,812.78View SEC Filing Icon  
12/29/2021Sell928$39.37$36,535.36View SEC Filing Icon  
12/15/2021Sell16,666$32.80$546,644.80View SEC Filing Icon  
12/13/2021Sell16,666$33.82$563,644.12View SEC Filing Icon  
12/9/2021Sell11,464$35.15$402,959.60View SEC Filing Icon  
12/7/2021Sell11,461$36.52$418,555.72View SEC Filing Icon  
11/4/2021Sell11,461$56.81$651,099.41View SEC Filing Icon  
11/2/2021Sell11,461$54.72$627,145.92View SEC Filing Icon  
10/14/2021Sell3,215$39.97$128,503.55View SEC Filing Icon  
10/7/2021Sell11,461$40.55$464,743.55View SEC Filing Icon  
10/5/2021Sell11,461$40.63$465,660.43View SEC Filing Icon  
9/28/2021Sell907$43.12$39,109.84View SEC Filing Icon  
9/9/2021Sell11,461$52.59$602,733.99276,923View SEC Filing Icon  
9/7/2021Sell11,461$52.50$601,702.50View SEC Filing Icon  
8/26/2021Sell848$57.26$48,556.48265,462View SEC Filing Icon  
8/5/2021Sell11,461$48.37$554,368.57View SEC Filing Icon  
8/3/2021Sell11,461$48.26$553,107.86277,771View SEC Filing Icon  
7/8/2021Sell11,464$46.15$529,063.60280,771View SEC Filing Icon  
7/6/2021Sell11,461$46.28$530,415.08280,771View SEC Filing Icon  
6/10/2021Sell11,461$36.47$417,982.67281,673View SEC Filing Icon  
6/8/2021Sell11,461$35.54$407,323.94281,673View SEC Filing Icon  
5/28/2021Sell802$33.87$27,163.74270,212View SEC Filing Icon  
5/6/2021Sell11,461$30.41$348,529.01282,475View SEC Filing Icon  
5/4/2021Sell11,461$30.15$345,549.15282,475View SEC Filing Icon  
4/8/2021Sell11,461$35.32$404,802.52273,988View SEC Filing Icon  
4/1/2021Sell10,149$36.53$370,742.97272,676View SEC Filing Icon  
3/26/2021Sell3,809$35.01$133,353.09246,522View SEC Filing Icon  
2/26/2021Sell861$39.57$34,069.77250,331View SEC Filing Icon  
2/19/2021Sell10,107$40.76$411,961.32210,354View SEC Filing Icon  
2/17/2021Sell9,917$41.55$412,051.35210,354View SEC Filing Icon  
12/1/2020Sell813$35.49$28,853.37202,843View SEC Filing Icon  
11/16/2020Sell34,383$31.80$1,093,379.40215,117View SEC Filing Icon  
11/12/2020Sell11,461$32.38$371,107.18215,117View SEC Filing Icon  
10/8/2020Sell18,750$28.55$535,312.50222,406View SEC Filing Icon  
10/6/2020Sell18,750$29.54$553,875.00222,406View SEC Filing Icon  
9/29/2020Sell4,690$28.63$134,274.70203,656View SEC Filing Icon  
9/10/2020Sell18,750$23.24$435,750.00227,096View SEC Filing Icon  
9/8/2020Sell18,750$21.64$405,750.00227,096View SEC Filing Icon  
8/26/2020Sell877$20.48$17,960.96208,346View SEC Filing Icon  
8/13/2020Sell18,750$18.64$349,500.00227,973View SEC Filing Icon  
8/11/2020Sell18,750$19.91$373,312.50227,973View SEC Filing Icon  
7/16/2020Sell18,750$19.30$361,875.00232,973View SEC Filing Icon  
7/14/2020Sell18,750$18.67$350,062.50232,973View SEC Filing Icon  
6/19/2020Sell18,750$16.37$306,937.50232,973View SEC Filing Icon  
6/11/2020Sell18,750$15.01$281,437.50232,973View SEC Filing Icon  
5/28/2020Sell516$16.87$8,704.92214,223View SEC Filing Icon  
5/15/2020Sell18,750$14.23$266,812.50233,489View SEC Filing Icon  
5/13/2020Sell18,750$15.45$289,687.50233,489View SEC Filing Icon  
4/15/2020Sell18,750$9.66$181,125.00233,489View SEC Filing Icon  
4/13/2020Sell18,750$9.03$169,312.50233,489View SEC Filing Icon  
3/12/2020Sell18,750$8.44$158,250.00184,574View SEC Filing Icon  
3/10/2020Sell18,750$12.16$228,000.00184,574View SEC Filing Icon  
2/26/2020Sell2,190$15.02$32,893.80165,824View SEC Filing Icon  
2/13/2020Sell18,750$14.17$265,687.50186,764View SEC Filing Icon  
2/11/2020Sell18,750$13.69$256,687.50186,764View SEC Filing Icon  
12/12/2019Sell10,247$15.11$154,832.17168,014View SEC Filing Icon  
12/10/2019Sell10,000$15.37$153,700.00168,014View SEC Filing Icon  
11/14/2019Sell10,000$13.98$139,800.00185,014View SEC Filing Icon  
11/12/2019Sell10,000$16.78$167,800.00185,014View SEC Filing Icon  
10/17/2019Sell10,000$16.26$162,600.00185,014View SEC Filing Icon  
10/15/2019Sell10,000$15.93$159,300.00185,014View SEC Filing Icon  
9/11/2019Sell14,571$19.36$282,094.56189,014View SEC Filing Icon  
9/9/2019Sell14,000$19.43$272,020.00189,014View SEC Filing Icon  
8/15/2019Sell9,905$18.07$178,983.35184,919View SEC Filing Icon  
8/13/2019Sell9,000$17.07$153,630.00184,014View SEC Filing Icon  
7/18/2019Sell18,903$16.29$307,929.87184,014View SEC Filing Icon  
7/16/2019Sell9,000$16.29$146,610.00184,014View SEC Filing Icon  
6/13/2019Sell18,903$17.37$328,345.11184,014View SEC Filing Icon  
6/11/2019Sell9,000$17.64$158,760.00184,014View SEC Filing Icon  
5/15/2019Sell7,088$16.94$120,070.72182,102View SEC Filing Icon  
4/10/2019Sell7,088$17.91$126,946.08182,102View SEC Filing Icon  
3/13/2019Sell7,088$17.19$121,842.72182,102View SEC Filing Icon  
2/13/2019Sell7,088$16.03$113,620.64146,605View SEC Filing Icon  
1/15/2019Sell14,781$12.14$179,441.34154,298View SEC Filing Icon  
12/13/2018Sell14,781$11.44$169,094.64154,298View SEC Filing Icon  
10/1/2018Sell12,540$17.57$220,327.80152,057View SEC Filing Icon  
9/5/2018Sell12,540$21.55$270,237.00152,057View SEC Filing Icon  
8/16/2018Sell12,540$19.50$244,530.00152,057View SEC Filing Icon  
7/16/2018Sell12,540$19.90$249,546.00152,057View SEC Filing Icon  
6/18/2018Sell12,540$12.89$161,640.60152,057View SEC Filing Icon  
5/15/2018Sell12,540$8.65$108,471.00152,057View SEC Filing Icon  
4/17/2018Sell12,540$7.18$90,037.20146,157View SEC Filing Icon  
3/15/2018Sell12,540$5.27$66,085.80View SEC Filing Icon  
2/15/2018Sell12,540$5.26$65,960.40152,057View SEC Filing Icon  
1/16/2018Sell12,540$5.57$69,847.80152,057View SEC Filing Icon  
5/14/2014Buy8,000$2.56$20,480.00View SEC Filing Icon  
5/13/2014Buy12,767$2.26$28,853.42View SEC Filing Icon  
See Full Table

Michael Rice Buying and Selling Activity at BioLife Solutions

This chart shows Michael Rice's buying and selling at BioLife Solutions by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BioLife Solutions Company Overview

BioLife Solutions logo
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; ultra-low temperature mechanical freezers; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services. It markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington.
Read More

Today's Range

Now: $13.30
Low: $12.86
High: $13.59

50 Day Range

MA: $12.14
Low: $8.99
High: $14.08

2 Week Range

Now: $13.30
Low: $8.92
High: $26.89


123,012 shs

Average Volume

404,726 shs

Market Capitalization

$585.60 million

P/E Ratio


Dividend Yield



New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
Check out this training for the full story!